David J Brayden

Title: David J Brayden: Innovator in Vaccine Formulations and Drug Absorption

Introduction

David J Brayden is a notable inventor based in Dublin, Ireland. He has made significant contributions to the fields of immunology and drug delivery systems. With a total of 2 patents, his work focuses on enhancing immune responses and improving drug absorption in the gastrointestinal tract.

Latest Patents

Brayden's latest patents include a method for inducing a cell-mediated immune response and improved parenteral vaccine formulations. This method involves inducing either a T1 polarized immune response, a T2 polarized immune response, or a combined T1 and T2 response to an antigen. The associated vaccine formulations utilize microparticles and nanoparticles that are designed to optimize immune responses. Additionally, he has developed a composition and method for enhancing transport across gastrointestinal tract cell layers. This composition features a non-ionic vegetable oil GIT absorption enhancer, which significantly increases the enteral absorbability of drugs, particularly hydrophilic and macromolecular drugs.

Career Highlights

Throughout his career, Brayden has worked with prominent companies such as Elan Corporation and Merrion Research Limited. His experience in these organizations has contributed to his expertise in vaccine development and drug delivery systems.

Collaborations

Brayden has collaborated with various professionals in his field, including his coworker Jacqueline M Dee. Their joint efforts have further advanced research in immunology and drug absorption.

Conclusion

David J Brayden is a distinguished inventor whose work has the potential to significantly impact vaccine efficacy and drug delivery. His innovative approaches continue to pave the way for advancements in medical science.